跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
HULIO adalimumab (rch) 20 mg/0.4 mL solution for injection pre-filled syringe
Approved
STANDARD
HULIO adalimumab (rch) 20 mg/0.4 mL solution for injection pre-filled syringe
Maxx Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
2b8dc25563bb75a8
Company
Maxx Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
2b8dc25563bb75a8
Product Name
HULIO adalimumab (rch) 20 mg/0.4 mL solution for injection pre-filled syringe
Artg Id
334801
Artg Name
HULIO adalimumab (rch) 20 mg/0.4 mL solution for injection pre-filled syringe
Sponsor
Maxx Pharma Pty Ltd
Company Detail Path
/organization/maxx-pharma-pty-ltd
Artg Date
2021-05-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
2b8dc25563bb75a8
Type
Standard
Back to TGA Approvals
HULIO adalimumab (rch) 20 mg/0.4 mL solution for injection pre-filled syringe - TGA Drug Approval Details